Roles of RNA-binding proteins in macrophage function regulation and immunotherapy
Macrophages are essential components of the innate immune system and exhibit remarkable functional plasticity, playing pivotal roles in inflammatory responses, maintenance of tissue homeostasis, and the initiation and progression of tumors as well as a wide range of other diseases. Accumulating evidence in recent years has demonstrated that, in addition to classical transcriptional regulation, post-transcriptional regulation is equally critical for macrophage fate determination and functional specialization. RNA-binding proteins (RBPs), as central regulators of post-transcriptional gene control, orchestrate a sophisticated and dynamic gene expression network by modulating RNA splicing, nucleocytoplasmic transport, stability and decay, translational efficiency, RNA epigenetic modifications, liquid-liquid phase separation, and chromatin-associated processes. Substantial experimental data indicate that RBPs are deeply involved in macrophage polarization, survival and programmed cell death, as well as metabolic reprogramming, thereby shaping the magnitude of inflammatory responses, immune suppressive states, and remodeling of the tumor microenvironment. In this review, we systematically summarize the molecular mechanisms by which RBPs regulate macrophage functions, with particular emphasis on their roles in inflammatory disorders, cancer, and metabolism-related diseases. We also highlight recent advances in the coordinated regulation of macrophage biology by RBPs in conjunction with RNA modifications, including m<sup>6</sup>A, m<sup>5</sup>C, and ac<sup>4</sup>C, as well as noncoding RNAs. Finally, we discuss the opportunities and challenges of targeting RBPs as emerging immunotherapeutic strategies, underscoring their potential in reprogramming the tumor immune microenvironment and enhancing the efficacy of immunotherapy, thereby providing a theoretical framework for the development of precise immune intervention approaches.
Authors
- Weiwei Bai
- Xiulin Jiang (ORCID: https://orcid.org/0000-0001-7986-0465)
- Chang Li (ORCID: https://orcid.org/0000-0002-3267-1859)
- J. Chen
- Yixiao Yuan
- Chongxin Li
- Qiang Zhou
- Qiang Wang
Institutions
- Petro-Canada (CA)
- Second People's Hospital of Yunnan Province (CN)
- Suizhou Central Hospital (CN)
- Qujing Normal University (CN)
- City of Hope (US)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.3389/fcell.2026.1771892
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00